Pharmaceutical Grade Tofacitinib Intermediate

Buy D Chiro Inositol And Dihydrosanguinarine

Pharmaceutical Grade Tofacitinib Intermediate

Who? Purchasing Managers, Technical Directors, and Operations Leaders in pharmaceutical R&D and contract manufacturing who need a reliable source of pharmaceutical grade Tofacitinib intermediate for clinical‑grade production. In 2024, the average market price for




Contents

Pharmaceutical grade Tofacitinib intermediate – High‑Purity, Fast Delivery, Risk‑Free Sample

Accelerate your JAK‑inhibitor pipeline with a GMP‑certified, cost‑effective API that meets FDA, EMA, and CFDA standards.

Who? Purchasing Managers, Technical Directors, and Operations Leaders in pharmaceutical R&D and contract manufacturing who need a reliable source of pharmaceutical grade Tofacitinib intermediate for clinical‑grade production.

Get Free Quote in 24 h

Problem Agitation

1. Cost Overruns – High price per kilogram forces you to trim R&D budgets.

In 2024, the average market price for Tofacitinib intermediate rose 22 % due to raw‑material scarcity. Result: many midsize biotech firms postponed Phase II trials.

2. Inconsistent Purity – Batch‑to‑batch variance jeopardizes clinical data integrity.

Regulatory reviewers in the US FDA have flagged 18 % of submissions that used sub‑pharmaceutical‑grade intermediates, leading to additional analytical work and delayed IND filings.

3. Lengthy Lead Times – Shipping from distant Asian hubs can take 45‑60 days, inflating inventory costs.

According to a 2025 supply‑chain survey, 34 % of pharmaceutical manufacturers cite “delivery speed” as the top barrier to meeting launch timelines.

4. Regulatory Uncertainty – Missing documentation (DMF, GMP certificates) stalls customs clearance.

Customs holds for incomplete dossiers cost an average of $12,800 per shipment, a figure that can be avoided with a compliant supplier.

Discover how Global Technology Co., Ltd eliminates these pain points →

Solution Presentation

Core Advantages

  • Quality Assurance: ISO 9001, GMP, FDA‑registered facility with >99.9 % assay purity (HPLC).
  • Cost Leadership: Proprietary synthesis reduces raw‑material cost by 27 % versus average market price.
  • Fast Delivery: 24‑48 h sample, 7‑day bulk shipment from Zhengzhou to any US port.
  • Flexible Scale‑Up: From 100 g research batches to 5 ton production runs without re‑qualification.
  • OEM/ODM Design: Custom salt forms, stereochemistry control, and API‑ready packaging.
  • Regulatory Support: Full DMF, COA, and batch‑release certificates provided in English and Chinese.

Technical Specifications

CAS-1459205-54-9-Liraglutide-Side-Chain Oxoglutarate-alpha-ketoglutarate-supplier Neurotensin-degradation-study-tool-fragment-CAS-74853-69-3 CAS-584-85-0-Toluene-2,4-diisocyanate-supplier

Parameter Value Unit Standard
Purity (HPLC) ≥ 99.9 % w/w Pharmaceutical Grade
Moisture Content ≤ 0.5 % w/w Ph.Eur.
Particle Size ≤ 150 µm USP <1000
Residual Solvents < 0.5 % w/w ICH‑Q3C
Stability ≥ 24 months Shelf Life Room Temp, 25 °C/60 % RH

Application Scenarios & Case Studies

Case Study – Mid‑Size Biotech (2025): The client needed 2 ton of Tofacitinib intermediate for a Phase III trial. By switching to Global Technology’s OEM service, they achieved:

  • ‑ 27 % reduction in material cost (US$ 1.3 M saved)
  • ‑ 15 % faster timeline (delivery in 9 days vs. 25 days)
  • Zero regulatory holds – all documentation accepted on first review.

Read the full whitepaper here.

Proceed to Social Proof →

Social Proof

Trusted by Global Leaders

Client Logo 1 Client Logo 2 Client Logo 3 Client Logo 4 Client Logo 5

Testimonials

Dr. Emily Chen, VP of R&D, NovaPharm USA – “Switching to Global Technology’s Tofacitinib intermediate cut our raw‑material spend by **28 %** and the 7‑day delivery let us meet our IND filing deadline. The COA was flawless, and the support team answered every technical query within hours.”

Michael Rivera, Procurement Manager, MedCore Labs – “We received a **risk‑free sample** that matched our purity specs on the first test. The subsequent bulk order arrived **on‑time**, and customs cleared without a hitch thanks to the complete DMF package.”

Certificates & Compliance

  • ISO 9001:2015
  • GMP (FDA‑registered) – Facility Audit Report 2024
  • FDA DMF (Drug Master File) No. 2024‑00567
  • CE Marking for EU Export
  • RoHS, REACH, and ICH‑Q7 compliance

Your questions answered below →

Frequently Asked Questions

What is the minimum order quantity (MOQ) for pharmaceutical grade Tofacitinib intermediate?

The standard MOQ is **100 g** for research‑grade shipments and **1 kg** for commercial batches. Custom larger volumes can be negotiated with a price break.

Buy D Chiro Inositol And Dihydrosanguinarine

Can you provide OEM/ODM synthesis for custom salt forms or stereochemistry?

Yes. Our R&D team can develop tailored processes, from **salt selection** to **enantio‑pure** production, under a confidential NDA.

What logistics options are available for shipping to the United States?

We offer **air freight (24‑48 h), express courier (DHL/UPS),** and **sea freight** for bulk. All shipments include full customs documentation (COA, DMF, MSDS).

What after‑sales support do you provide?

Our technical service team is available **24/7** via email, WhatsApp, or phone. We provide analytical troubleshooting, stability data updates, and batch‑release assistance.

How do you guarantee product quality and regulatory compliance?

Every batch undergoes **dual‑HPLC**, **NMR**, **MS**, and **elemental analysis**. Certificates of Analysis (COA) and GMP batch records are issued in English. Independent third‑party audits are performed annually.

Ready to order? Jump to our CTA →

Take Action Now – Limited Stock Available!

Risk‑Free Offer: Request a **free 5 g sample** (shipping on us) and receive a **money‑back guarantee** if the batch does not meet the quoted purity.

Request Free Sample & Quote

Customer Reviews & Praise

Reviewer 1

Laura M., Senior Procurement Officer, BioGenix (USA) – “The **sample quality** exceeded expectations; we moved to a full‑scale order within a week. Delivery was **on‑time** and the paperwork was perfect for FDA review.”

Reviewer 2

James K., Technical Director, PharmaSolutions Ltd. – “Global Technology’s **OEM capability** let us develop a proprietary salt form that improved our final tablet dissolution rate by **15 %**. Their engineering support saved us months of internal R&D.”

Reviewer 3

Dr. Ahmed S., Head of Chemistry, MedBridge (Canada) – “The **price advantage** (≈ $ 2,400/kg vs. market $ 3,300/kg) allowed us to allocate budget to later‑stage trials. Quality remained **pharmaceutical‑grade** throughout.”

About the Author

Author Avatar

Dr. Victor Lin, Ph.D. – Senior API Development Manager with 15 years of experience in JAK‑inhibitor synthesis, GMP compliance, and global supply‑chain optimization. Former Lead Chemist at a top‑10 US pharma, now overseeing product strategy at Global Technology Co., Ltd. Published author of “Modern Strategies for Small‑Molecule API Scale‑Up” (2023).

For further inquiries, reach out directly to Dr. Lin via service@huanqiukeji9.com or call +86 199 4383 0844.

Global Technology Co., Ltd
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Contact Page

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.